[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-351166-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-351166-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","enzymatic-remodelling-of-tumour-microenvironment-enhances-anti-ceacam5-car-t-cell-efficacy-against-colorectal-cancer","Enzymatic Remodelling of Tumour Microenvironment Enhances Anti-CEACAM5 CAR T-Cell Efficacy Against Colorectal Cancer","","Chimeric antigen receptor (CAR) T-cell therapy shows major benefits in haematological cancers but remains challenged in solid tumours. This study examines CEACAM5-targeting primary CAR T-cell interactions with colorectal cancer (CRC) cells using fluorescence microscopy. CRC cells exhibit a much thicker glycocalyx, causing delayed activation and non-sustained CAR T calcium signalling. Progressive loss of accessible CEACAM5 correlates with reduced cytotoxicity in longer-seeded monolayers, likely via antigen sequestration at junctions. Proteolytic trypsin and hyaluronidase treatments disrupt the monolayer, reduce glycocalyx thickness, restore sustained calcium fluxes, and enhance cytotoxicity and TNF-α secretion. Limited CEACAM5 accessibility in human CRC tissues is increased by these enzymes, highlighting a mechanism and potential therapy route.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/enzymatic-remodelling-of-tumour-microenvironment-enhances-anti-ceacam5-car-t-cell-efficacy-against-colorectal-cancer/351166/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/enzymatic-remodelling-of-tumour-microenvironment-enhances-anti-ceacam5-car-t-cell-efficacy-against-colorectal-cancer/351166.png","ImageObject",300,407,{"name":42,"@type":43},"Genevieve","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-28","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why are anti-CEACAM5 CAR T-cells ineffective against colorectal cancer?","Question",{"text":63,"@type":64},"CRC cells show a much thicker glycocalyx and reduced accessibility of the CEACAM5 antigen over time, likely due to sequestration at intercellular junctions. This leads to delayed, non-sustained CAR T-cell activation and decreased cytotoxicity.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What enzymatic interventions were tested to improve CAR T-cell efficacy?",{"text":68,"@type":64},"Local proteolytic trypsin treatment and hyaluronidase treatment were used to disrupt the CRC cell monolayer. Both approaches increased CEACAM5 availability and decreased glycocalyx thickness.",{"name":70,"@type":61,"acceptedAnswer":71},"How did enzyme treatment affect CAR T-cell signalling and immune function?",{"text":72,"@type":64},"Enzyme treatment restored sustained CAR T-cell calcium fluxes compared with untreated conditions. It also enhanced CAR T-cell-mediated cytotoxicity and increased the percentage of TNF-α–secreting CAR T cells.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},351166,1790193948,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1374391974585,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Advanced Science    \n[www.advancedscience.com](www.advancedscience.com)  \n RESEARCH ARTICLE   \nEnzymatic Remodelling of Tumour Microenvironment Enhances Anti-CEACAM5 CAR T-Cell Efficacy Against Colorectal Cancer  \nDebasis Banik1   Christopher J. Ward2  Soura Chakraborty2  Ziwei Zhang1  Daniel Heraghty1  Prasanna Suresh1 Bing Li1  Shekhar Kedia1  Jhuma Pramanik2  Simon J. Davis3, 4  James P. Roy5  Michael A. Chapman5, 6, 7  Bidesh Mahata2  David Klenerman1   \n1Yusuf Hamied Department of Chemistry, University of Cambridge, Cambridge, UK  2 Department of Pathology, University of Cambridge, Cambridge, UK  3 Radcliffe Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK  4Medical Research Council Translational Immune Discovery Unit, John Radcliffe Hospital, University of Oxford, Oxford, UK  5MRC Toxicology Unit, University of Cambridge, Cambridge, UK  6 Department of  \nHaematology, University of Cambridge, Cambridge, UK  7Addenbrooke’s Hospital, Cambridge Universities Foundation Trust, Cambridge, UK Correspondence: Debasis Banik ([db920@cam.ac.uk](db920@cam.ac.uk))  Bidesh Mahata (bm562@cam.ac.uk)  David Klenerman (dk10012@cam.ac.uk)  \nReceived: 28 May 2025  Revised: 8 December 2025  Accepted: 9 December 2025  \nKeywords: CAR T cell | CEACAM5 | CRC | enzyme | glycocalyx  \nABSTRACT  \nChimeric antigen receptor (CAR) T-cell therapy has shown unprecedented success in haematological cancers but faces challenges in solid tumours. Although carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5) is differentially expressed in many solid tumours, anti-CEACAM5 CAR T-cells are ineffective. Here, we have studied the interaction of CEACAM5 targeting primary CAR T-cells with colorectal cancer (CRC) cells using fluorescence microscopy. We found that CRC cells’ glycocalyx is much thicker than that of the CAR T cell causing delayed activation. Oscillating calcium fluxes, indicative of non-sustained CAR T cell activation, are observed when CAR T cells interacted with CRC cells, which increased with increasing cell-seeding time. Significant reduction in cytotoxicity is observed on going from early to longer-seeded CRC monolayers. Imaging revealed that this effect correlated with a progressive loss of accessible CEACAM5 antigen on the CRC cell surface, possibly due to their sequestration in the intercellular junction, rendering CART cell engagement less effective. Local proteolytic treatment with trypsinto disrupt the CRC cell monolayer, using a micropipette, increased CEACAM5 availability, decreased glycocalyx thickness, and restored sustained CART cell calcium fluxes. Similar enhanced interaction is observed after treatment ofCRC cell monolayer with hyaluronidase, approved for use in humans. Enzymatic treatment significantly enhanced CAR T cell-mediated cytotoxicity and increased the percentage of TNF-α–secreting CAR T cells. We observed limited availability of CEACAM5 on human colorectal cancer tissues, whereas treatment with trypsin or hyaluronidase increased accessibility. Our results reveal why CAR T cells targeting CEACAM5 are ineffective and suggest possible routes to improved therapy for CRC.  \n1  Introduction  \nT cells are an essential part of the adaptive immune system. Each T cell expresses T-cell receptors (TCRs) which recognise peptide major histocompatibility complexes (pMHCs) on the  \nsurface of antigen-presenting cells (APCs) . In contrast, synthetically designed chimeric antigen receptors (CARs) originally comprised target-binding single-chain variable fragments (scFvs) of antibodies connected to an intracellular signaling domain, i.e., that of the CD3ζ subunit of the TCR, via a transmembrane  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n© 2026 The Author(s). Advanced Science published by Wiley-VCH GmbH  \nAdvanced Science, 2026; 13:e0976","cbCaiuseUt26xLp6","https://ap.wps.com/l/cbCaiuseUt26xLp6","pdf",8657541,18,"English","# Abstract\n# Introduction","[{\"question\":\"Why are anti-CEACAM5 CAR T-cells ineffective against colorectal cancer?\",\"answer\":\"CRC cells show a much thicker glycocalyx and reduced accessibility of the CEACAM5 antigen over time, likely due to sequestration at intercellular junctions. This leads to delayed, non-sustained CAR T-cell activation and decreased cytotoxicity.\"},{\"question\":\"What enzymatic interventions were tested to improve CAR T-cell efficacy?\",\"answer\":\"Local proteolytic trypsin treatment and hyaluronidase treatment were used to disrupt the CRC cell monolayer. Both approaches increased CEACAM5 availability and decreased glycocalyx thickness.\"},{\"question\":\"How did enzyme treatment affect CAR T-cell signalling and immune function?\",\"answer\":\"Enzyme treatment restored sustained CAR T-cell calcium fluxes compared with untreated conditions. It also enhanced CAR T-cell-mediated cytotoxicity and increased the percentage of TNF-α–secreting CAR T cells.\"}]","Enzymatic Remodelling of Tumour Microenvironment Enhances Anti-CEACAM5 CAR T-Cell Efficacy Against Colorectal Cancer | PDF",1790092893,45,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f7aca1c1d04ba0131ce3fd4315f60e33.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/594cf778553b37ec19d8fbe9952e0037.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1ba8041f0a087707875f53edba5e44f8.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4a54b881c0bf7291c679b841c937189e.webp",980,1287]